Competition in Health Insurance Markets

The U.S. Health insurance landscape is increasingly concentrated, raising concerns about its impact on premiums, plan designs, and consumer welfare. A recent analysis highlights how market power and informational asymmetries—particularly adverse selection—interact to shape these outcomes. The findings underscore the need for robust regulation and antitrust oversight to ensure a competitive and functioning health insurance system.

Growing Consolidation in Health Insurance

Approximately 238 million Americans—78 percent of those with health insurance and 70 percent of the total population—obtain coverage through private health insurance companies [AHIP]. While most receive insurance through their employer, a growing number are enrolled in publicly subsidized private insurance plans, such as those offered through Medicare Advantage.

Over the past several decades, the health insurance industry has experienced significant consolidation. This trend, observed across commercial, Medicare Advantage, and Medicaid markets, raises questions about its effects on competition and consumer choice.

The Role of Adverse Selection and Market Power

Health insurance markets are characterized by inherent complexities, notably imperfect information and adverse selection. Adverse selection occurs when individuals with higher health risks are more likely to purchase insurance, potentially driving up premiums for everyone. Insurance companies respond to these challenges by structuring policies to attract healthier enrollees and, at times, limiting care in ways that are hard to observe.

As market concentration increases, the interplay between market power and adverse selection becomes critical. Insurer consolidation can lead to higher premiums, reduced coverage options, and limited plan choices for consumers. The analysis suggests that these dynamics require careful monitoring and intervention.

Medicare Advantage and Antitrust Scrutiny

The consolidation within the Medicare Advantage program has specifically drawn the attention of antitrust enforcers [Medicare.gov]. Medicare Advantage plans, offered by Medicare-approved private companies, provide an alternative to Original Medicare (Parts A and B). These plans often include prescription drug coverage (Part D).

Different types of Medicare Advantage Plans are available, including Health Maintenance Organizations (HMOs), Preferred Provider Organizations (PPOs), Special Needs Plans (SNPs), Medicare Medical Savings Accounts (MSAs), and Private Fee-for-Service Plans (PFFS) [Medicare.gov].

Policy Recommendations

The researchers emphasize the need for a comprehensive approach to regulating health insurance markets. They recommend a combination of effective regulation, robust antitrust oversight, and interventions to address informational asymmetries. They also suggest that a single entity responsible for monitoring, oversight, and policy implementation across all health insurance markets—rather than separate entities for each state—could be beneficial.

“Health insurance in the United States is provided mainly through markets, and how competition functions in health insurance markets is a key factor in determining how well the U.S. System of health care works,” explains Amanda Starc, professor of strategy at Northwestern University’s Kellogg School of Management. “But these markets don’t work as well as they could or should. The substantial market imperfections in this sector, both due to asymmetric information and due to market power, require significant monitoring and oversight to improve market performance.”

Looking Ahead

Addressing the challenges of competition and consolidation in health insurance markets is crucial for ensuring affordable, accessible, and high-quality healthcare for all Americans. Ongoing monitoring, effective regulation, and proactive antitrust enforcement will be essential to fostering a competitive landscape and protecting consumer welfare.